Literature DB >> 10655530

Correction of the hyper-IgM syndrome after liver and bone marrow transplantation.

N Hadzić1, A Pagliuca, M Rela, B Portmann, A Jones, P Veys, N D Heaton, G J Mufti, G Mieli-Vergani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10655530     DOI： 10.1056/NEJM200002033420504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  Clinical course of patients with major histocompatibility complex class II deficiency.

Authors:  M A Saleem; P D Arkwright; E G Davies; A J Cant; P A Veys
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

Review 3.  Update on the hyper immunoglobulin M syndromes.

Authors:  E Graham Davies; Adrian J Thrasher
Journal:  Br J Haematol       Date:  2010-02-23       Impact factor: 6.998

Review 4.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

Review 5.  Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease.

Authors:  Hitomi Hosoya; Jeffrey Levine; Peter Abt; David Henry; David L Porter; Saar Gill
Journal:  Blood Adv       Date:  2018-03-13

Review 6.  Hematopoietic stem cell transplantation for primary immunodeficiencies.

Authors:  Elizabeth Kang; Andrew Gennery
Journal:  Hematol Oncol Clin North Am       Date:  2014-09-16       Impact factor: 3.722

Review 7.  The hyper IgM syndromes.

Authors:  Nashmia Qamar; Ramsay L Fuleihan
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

8.  Bone marrow transplantation for CD40 ligand deficiency: a single centre experience.

Authors:  K Khawaja; A R Gennery; T J Flood; M Abinun; A J Cant
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

9.  Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.

Authors:  M Teresa de la Morena; David Leonard; Troy R Torgerson; Otavio Cabral-Marques; Mary Slatter; Asghar Aghamohammadi; Sharat Chandra; Luis Murguia-Favela; Francisco A Bonilla; Maria Kanariou; Rongras Damrongwatanasuk; Caroline Y Kuo; Christopher C Dvorak; Isabelle Meyts; Karin Chen; Lisa Kobrynski; Neena Kapoor; Darko Richter; Daniela DiGiovanni; Fatima Dhalla; Evangelia Farmaki; Carsten Speckmann; Teresa Español; Anna Shcherbina; Imelda Celine Hanson; Jiri Litzman; John M Routes; Melanie Wong; Ramsay Fuleihan; Suranjith L Seneviratne; Trudy N Small; Ales Janda; Liliana Bezrodnik; Reinhard Seger; Andrea Gomez Raccio; J David M Edgar; Janet Chou; Jordan K Abbott; Joris van Montfrans; Luis Ignacio González-Granado; Nancy Bunin; Necil Kutukculer; Paul Gray; Gisela Seminario; Srdjan Pasic; Victor Aquino; Christian Wysocki; Hassan Abolhassani; Morna Dorsey; Charlotte Cunningham-Rundles; Alan P Knutsen; John Sleasman; Beatriz Tavares Costa Carvalho; Antonio Condino-Neto; Eyal Grunebaum; Helen Chapel; Hans D Ochs; Alexandra Filipovich; Mort Cowan; Andrew Gennery; Andrew Cant; Luigi D Notarangelo; Chaim M Roifman
Journal:  J Allergy Clin Immunol       Date:  2016-09-30       Impact factor: 10.793

10.  Type І hyper IgM syndrome with novel mutation from India.

Authors:  Rashid H Merchant; Javed Ahmed; Noor Ahmed; Capucine Picard
Journal:  Indian J Pediatr       Date:  2013-04-19       Impact factor: 1.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.